Tomohiko Ichikawa

10PUBLICATIONS
34CO-AUTHORS
Radiation therapyMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 18, 2026
Safety of carbon-ion radiotherapy for prostate cancer after rectal surgery: a single-institution retrospective study.

|Sep 27, 2025
Carbon-Ion Radiotherapy for Prostate Cancer in Patients with a History of Surgery for Benign Prostatic Hyperplasia.

Atsushi Okato, Kosei Miura, Tomoki Yamaguchi

|Jul 20, 2025
Consecutive real-world treatment experience with a reduced starting dose of lenvatinib (14 mg) plus pembrolizumab for metastatic renal cell carcinoma.

Tomokazu Sazuka, Kentaro Murakami, Hidetaka Nihei

|Feb 12, 2025
Novel FBN1 intron variant causes isolated ectopia lentis via in-frame exon skipping.

Norihiro Shimizu, Yoichi Mashimo, Hirotaka Yokouchi

|Jul 13, 2024
TNFSF9 Is Associated with Favorable Tumor Immune Microenvironment in Patients with Renal Cell Carcinoma Who Are Treated with the Combination Therapy of Nivolumab and Ipilimumab.

Bunpei Isoda, Shuya Kandori, Tomokazu Sazuka

|Oct 27, 2023
Identification of Early Biochemical Recurrence Predictors in High-Risk Prostate Cancer Patients Treated with Carbon-Ion Radiotherapy and Androgen Deprivation Therapy.

Takanobu Utsumi, Hiroyoshi Suzuki, Hitoshi Ishikawa

Pageof 2

Frequent Collaborators

3 joint publications

Hitoshi Ishikawa

3 joint publications

Tomokazu Sazuka

2 joint publications

Atsushi Okato

2 joint publications

Takanobu Utsumi